Thalamic nuclei degeneration in multiple sclerosis.


Journal

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
ISSN: 1532-2653
Titre abrégé: J Clin Neurosci
Pays: Scotland
ID NLM: 9433352

Informations de publication

Date de publication:
Jul 2021
Historique:
received: 24 07 2020
revised: 05 10 2020
accepted: 23 05 2021
pubmed: 7 6 2021
medline: 20 7 2021
entrez: 6 6 2021
Statut: ppublish

Résumé

To define both the severity and extent of structural alteration in certain thalamic nuclei by means of MR morphometry and to compare these findings with clinical performance in different phenotypes of multiple sclerosis (MS). We comparatively measured the thalamus nuclei volumes of patients with remitting-relapsing (RRMS) and secondary-progressive (SPMS) phenotypes of multiple sclerosis and healthy control subjects (HC). The evaluation of neurological performance was based on the results of Expanded Disability Status Scale and Multiple Sclerosis Severity Scale. Cognitive and mental state was rated according to the results of Mini-Mental State Examination, Frontal Assessment Battery, Montreal Cognitive Assessment and Symbol Digit Modalities Test. Freesurfer 6.0 was used for thalamic nuclei volumes calculation. The median volume decline in thalamic pulvinar nuclei in RRMS group on the left side (anterior nucleus - 186,6 mm These findings indicate the credible correlation between clinical progression of neurological and cognitive impairment in MS patients with asymmetry left-sided thalamic nuclei atrophy and may be considered a potential predicting tool of MS progression.

Identifiants

pubmed: 34090763
pii: S0967-5868(21)00261-7
doi: 10.1016/j.jocn.2021.05.043
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

375-380

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Artem Trufanov (A)

Department of Nanobiotechnology, Autonomous Non-profit Higher Education Organization (University associated with the Interparliamentary Assembly of the Eurasian Economic Community), 14/1, letter B, Smolyachkova Street, 194044 Saint-Petersburg, Russia; Department of Neurology, Kirov Military Medical Academy, 6, Lebedeva Street, 194044 Saint-Petersburg, Russia. Electronic address: trufanovart@gmail.com.

Gennady Bisaga (G)

Department of Neurology, Almazov National Medical Research Centre, 2, Akkuratova Street, 197341 Saint-Petersburg, Russia.

Dmitry Skulyabin (D)

Department of Neurology, Kirov Military Medical Academy, 6, Lebedeva Street, 194044 Saint-Petersburg, Russia.

Alexandr Temniy (A)

Department of Neurology, Kirov Military Medical Academy, 6, Lebedeva Street, 194044 Saint-Petersburg, Russia.

Mariya Poplyak (M)

Department of Neurology, Kirov Military Medical Academy, 6, Lebedeva Street, 194044 Saint-Petersburg, Russia.

Oleg Chakchir (O)

Department of Nanobiotechnology, Autonomous Non-profit Higher Education Organization (University associated with the Interparliamentary Assembly of the Eurasian Economic Community), 14/1, letter B, Smolyachkova Street, 194044 Saint-Petersburg, Russia.

Aleksandr Efimtsev (A)

Department of Radiology, Almazov National Medical Research Centre, 2, Akkuratova Street, 197341 Saint-Petersburg, Russia.

Tarumov Dmitriy (T)

Department of Psychiatry, Kirov Military Medical Academy, 6, Lebedeva Street, 194044 Saint-Petersburg, Russia.

Miroslav Odinak (M)

Department of Neurology, Kirov Military Medical Academy, 6, Lebedeva Street, 194044 Saint-Petersburg, Russia.

Igor Litvinenko (I)

Department of Neurology, Kirov Military Medical Academy, 6, Lebedeva Street, 194044 Saint-Petersburg, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH